INTERNATIONAL PATENT: TETHEREX PHARMACEUTICALS CORPORATION FILES APPLICATION FOR "ANTIBODIES AND METHODS OF TREATMENT"

GENEVA, Sept. 21 -- TETHEREX PHARMACEUTICALS CORPORATION (840 Research ParkwayOklahoma City, Oklahoma 73104) filed a patent application (PCT/IB2025/052733) for "ANTIBODIES AND METHODS OF TREATMENT" on Mar 14, 2025. With publication no. WO/2025/191536, the details related to the patent application was published on Sep 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ROTHER, Russell (c/o Tetherex Pharmaceuticals Corporation840 Research ParkwayOklahoma City, Oklahoma 73104)

Abstract: The invention provides humanised anti-PSGL-1 antibodies and their therapeutic uses for the prevention and ...